Primary refractory B-cell lymphoblastic leukemia with extramedullary disease – a distinctive response to blinatumomab and inotuzumab ozogamicin

Detalles Bibliográficos
Autores principales: Silva, Wellington Fernandes da, Marquez, Gabriel Lacerda, Salim, Rafael Calil, Rocha, Vanderson
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2019
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978496/
https://www.ncbi.nlm.nih.gov/pubmed/31582343
http://dx.doi.org/10.1016/j.htct.2018.11.004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6978496/
https://www.ncbi.nlm.nih.gov/pubmed/31582343
http://dx.doi.org/10.1016/j.htct.2018.11.004

Ejemplares similares